Business Description
Shanghai Boxun Medical Biological Instrument Corp
ISIN : CNE100006632
Compare
Compare
Traded in other countries / regions
836504.China IPO Date
2023-08-17Description
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products and purification safety series products, etc.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.76 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 1.41 | |||||
| Interest Coverage | 17.43 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.98 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.1 | |||||
| 3-Year EBITDA Growth Rate | 4.7 | |||||
| 3-Year EPS without NRI Growth Rate | 4 | |||||
| 3-Year FCF Growth Rate | -8.9 | |||||
| 3-Year Book Growth Rate | 15.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.09 | |||||
| 9-Day RSI | 54.35 | |||||
| 14-Day RSI | 55.82 | |||||
| 6-1 Month Momentum % | -32.74 | |||||
| 12-1 Month Momentum % | 8.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.02 | |||||
| Quick Ratio | 3.22 | |||||
| Cash Ratio | 2.25 | |||||
| Days Inventory | 149.42 | |||||
| Days Sales Outstanding | 58.52 | |||||
| Days Payable | 81.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 48.81 | |||||
| Dividend Payout Ratio | 14.52 | |||||
| Forward Dividend Yield % | 48.81 | |||||
| 5-Year Yield-on-Cost % | 48.81 | |||||
| 3-Year Average Share Buyback Ratio | -7.1 | |||||
| Shareholder Yield % | 46.55 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.71 | |||||
| Operating Margin % | 12.71 | |||||
| Net Margin % | 14.9 | |||||
| FCF Margin % | -0.77 | |||||
| ROE % | 10.56 | |||||
| ROA % | 7.88 | |||||
| ROIC % | 12.34 | |||||
| ROC (Joel Greenblatt) % | 35.15 | |||||
| ROCE % | 10.85 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.65 | |||||
| PE Ratio without NRI | 27.32 | |||||
| Shiller PE Ratio | 20.51 | |||||
| Price-to-Owner-Earnings | 54.76 | |||||
| PEG Ratio | 1.53 | |||||
| PS Ratio | 4.25 | |||||
| PB Ratio | 3.12 | |||||
| Price-to-Tangible-Book | 3.29 | |||||
| Price-to-Free-Cash-Flow | 255.66 | |||||
| Price-to-Operating-Cash-Flow | 26.63 | |||||
| EV-to-EBIT | 26.5 | |||||
| EV-to-EBITDA | 26.5 | |||||
| EV-to-Revenue | 4.49 | |||||
| EV-to-FCF | -581.69 | |||||
| Price-to-Projected-FCF | 5.04 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.02 | |||||
| Price-to-Graham-Number | 2 | |||||
| Price-to-Net-Current-Asset-Value | 6.19 | |||||
| Price-to-Net-Cash | 21.85 | |||||
| Earnings Yield (Greenblatt) % | 3.77 | |||||
| FCF Yield % | -0.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Boxun Medical Biological Instrument Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 130.912 | ||
| EPS (TTM) (Â¥) | 0.49 | ||
| Beta | 0 | ||
| Volatility % | 109.53 | ||
| 14-Day RSI | 55.82 | ||
| 14-Day ATR (Â¥) | 1.177214 | ||
| 20-Day SMA (Â¥) | 11.694 | ||
| 12-1 Month Momentum % | 8.95 | ||
| 52-Week Range (Â¥) | 8.15 - 25.5 | ||
| Shares Outstanding (Mil) | 43.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Boxun Medical Biological Instrument Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Boxun Medical Biological Instrument Corp Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Boxun Medical Biological Instrument Corp Frequently Asked Questions
What is Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504)'s stock price today?
The current price of BJSE:836504 is ¥13.55. The 52 week high of BJSE:836504 is ¥25.50 and 52 week low is ¥8.15.
When is next earnings date of Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504)?
The next earnings date of Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504) is .
Does Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504) is 48.81% (As of Today), Highest Dividend Payout Ratio of Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504) was 14.52. The lowest was 9.41. And the median was 9.41. The  Forward Dividend Yield % of Shanghai Boxun Medical Biological Instrument Corp(BJSE:836504) is 48.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers